Your browser doesn't support javascript.
loading
Retention of Alzheimer Disease Research Participants.
Grill, Joshua D; Kwon, Jimmy; Teylan, Merilee A; Pierce, Aimee; Vidoni, Eric D; Burns, Jeffrey M; Lindauer, Allison; Quinn, Joseph; Kaye, Jeff; Gillen, Daniel L; Nan, Bin.
Afiliação
  • Grill JD; Institute for Memory Impairments and Neurological Disorders.
  • Kwon J; Institute for Clinical and Translational Science.
  • Teylan MA; Departments of Psychiatry and Human Behavior.
  • Pierce A; Neurobiology and Behavior.
  • Vidoni ED; Statistics, University of California, Irvine, Irvine, CA.
  • Burns JM; National Alzheimer's Coordinating Center, University of Washington, Seattle, WA.
  • Lindauer A; Layton Center on Aging and Alzheimer's Disease, Oregon Health & Science University, Portland, OR.
  • Quinn J; University of Kansas Alzheimer's Disease Center, Fairway, KS.
  • Kaye J; University of Kansas Alzheimer's Disease Center, Fairway, KS.
  • Gillen DL; Layton Center on Aging and Alzheimer's Disease, Oregon Health & Science University, Portland, OR.
  • Nan B; Layton Center on Aging and Alzheimer's Disease, Oregon Health & Science University, Portland, OR.
Alzheimer Dis Assoc Disord ; 33(4): 299-306, 2019.
Article em En | MEDLINE | ID: mdl-31567302
INTRODUCTION: Participant retention is important to maintaining statistical power, minimizing bias, and preventing scientific error in Alzheimer disease and related dementias research. METHODS: We surveyed representative investigators from NIH-funded Alzheimer's Disease Research Centers (ADRC), querying their use of retention tactics across 12 strategies. We compared survey results to data from the National Alzheimer's Coordinating Center for each center. We used a generalized estimating equation with independent working covariance model and empirical standard errors to assess relationships between survey results and rates of retention, controlling for participant characteristics. RESULTS: Twenty-five (83%) responding ADRCs employed an average 42 (SD=7) retention tactics. In a multivariable model that accounted for participant characteristics, the number of retention tactics used by a center was associated with participant retention (odds ratio=1.68, 95% confidence interval: 1.42, 1.98; P<0.001 for the middle compared with the lowest tertile survey scores; odds ratio=1.59, 95% confidence interval: 1.30, 1.94; P<0.001 for the highest compared with the lowest tertile survey scores) at the first follow-up visit. Participant characteristics such as normal cognition diagnosis, older age, higher education, and Caucasian race were also associated with higher retention. CONCLUSIONS: Retention in clinical research is more likely to be achieved by employing a variety of tactics.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ensaios Clínicos como Assunto / Seleção de Pacientes / Pesquisa Biomédica / Doença de Alzheimer Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ensaios Clínicos como Assunto / Seleção de Pacientes / Pesquisa Biomédica / Doença de Alzheimer Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article